Company intelligence / Profile preview

Cidara Therapeutics

San Diego, California, United Statesannualreports.com ↗

Ownership: Public · CDTX
Development stage: Commercial

Overview

The company’s lead candidate, CD388, a long-lasting antiviral targeting universal influenza prevention, completed enrollment of a large Phase 2b NAVIGATE trial with potential early efficacy data expected mid-year 2025. The oncology candidate CBO421 received IND clearance in July 2024 to target solid tumors expressing CD73. Additional programs are at earlier stages.

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: Drug-Fc conjugates (DFCs)Small molecules (as payloads in DFCs)Peptides (as payloads in DFCs)
Industry: Biotech

Drug pipeline

7 assets

rezafungin

Approved

6 more assets in the full pipeline.

Request access →

Partnerships

Johnson & Johnson/Janssen Pharmaceuticals – previous collaboration on influenza therapy rights; reacquired by Cidara in April 2024WuXi XDC – chemistry/manufacturing services for oncology programNapp Pharmaceutical Group Limited/Mundipharma – divestiture agreement for rezafungin asset

Financials

Market cap: $5.6B
Total revenue: $0
Enterprise value: $5.3B

Beyond the preview

Go deeper on Cidara Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cidara Therapeutics.

Explore the full profile